The chemical biology of new drugs in the development for tuberculosis
Authors:
- Clifton E BarryCBClifton E Barry
- John S BlanchardJBJohn S Blanchard
- 1 August 2010
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 14 (4) , 456-466
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2009
- Role of reactive oxygen species in antibiotic action and resistanceCurrent Opinion in Microbiology, 2009
- Linezolid: a review of safety and tolerabilityJournal of Infection, 2009
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO ReleaseScience, 2008
- Structure of the Covalent Adduct Formed between Mycobacterium tuberculosis β-Lactamase and ClavulanateBiochemistry, 2008
- Crystal Structure and Activity Studies of the Mycobacterium tuberculosis β-Lactamase Reveal Its Critical Role in Resistance to β-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 2006
- Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in MiceAntimicrobial Agents and Chemotherapy, 2006
- Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediaminesJournal of Antimicrobial Chemotherapy, 2005
- Recombinant Expression and Characterization of the Major β-Lactamase of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998
- The Chemotherapy of Pulmonary Tuberculosis: A ReviewChest, 1979